Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress

被引:43
|
作者
Cookson, MR
Menzies, FM
Manning, P
Eggett, CJ
Figlewicz, DA
McNeil, CJ
Shaw, PJ
机构
[1] Univ Sheffield, Sch Med, Dept Neurol, Acad Neurol Unit, Sheffield S10 2RX, S Yorkshire, England
[2] Univ Newcastle Upon Tyne, Dept Clin Biochem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[3] Univ Rochester, Dept Neurol & Neurobiol & Anat, Rochester, NY 14627 USA
来源
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS | 2002年 / 3卷 / 02期
关键词
amyotrophic lateral sclerosis; SOD1; mutations; nitric oxide; superoxide; neuroprotection;
D O I
10.1080/146608202760196048
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: The exact molecular mechanisms by which mutations in Cu/Zn superoxide dismutase (SOD1) cause motor neuron injury remain incompletely understood, though a body of evidence suggests that the mutant protein exerts a cell-specific toxic gain of function. The role of nitric oxide (NO) in SOD1-related motor neuron injury has been particularly controversial. Theoretically, there are arguments to suggest that NO may exert an important role in motor neuron injury, but there is relatively little direct experimental support for this hypothesis. Objectives: The present study aimed to examine further the potential role for NO in motor neuron injury caused by mutant SOD1. Method: We have generated a cellular model of familial amyotrophic lateral sclerosis (ALS) by stably transfecting NSC34 cells with one of three mutant forms of SOD1 (G93A, G37R, I113T). In the presence of mutant SOD1, NSC34 cells show increased cell death following oxidative stress induced by serum withdrawal. This model of motor neuron death involves cellular release of superoxide and NO radicals, which were directly measured in real time using microelectrode biosensors. Results: The expression of both normal and mutant SOD1 decreased the measured extracellular superoxide release, but had divergent effects on the measured release of NO. Normal SOD1 increased the measured NO release, whereas cells expressing mutant SOD1 released less NO. Co-administration of two different nitric oxide synthase inhibitors (L-NAME and L-N-methyl arginine) did show some neuroprotective effect, but this was only partial, and the effect was more marked using nuclear integrity as a measure of cell viability, rather than MTT conversion. Cells expressing mutant SOD1 were, however, more sensitive to toxicity induced by extrinsic exposure to NO, using a slow-release NO donor. Conclusion: NO is likely to contribute to motor neuron injury, but this does not fully account for all the cellular toxic effects of mutant SOD1.
引用
收藏
页码:75 / 85
页数:11
相关论文
共 50 条
  • [21] Fighting against amyotrophic lateral sclerosis (ALS) with flavonoids: a computational approach to inhibit superoxide dismutase (SOD1) mutant aggregation
    Varnosfaderani, Seyed Mostafa Noorbakhsh
    Haeri, Melika Sadat
    Arian, Ali Sam
    Rad, Ali Yousefi
    Yazdanpour, Mohammad
    Mojahedian, Fatemeh
    Yaghoubzad-Maleki, Mohammad
    Zalpoor, Hamidreza
    Baziyar, Payam
    Nabi-Afjadi, Mohsen
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2025, 43 (01) : 419 - 436
  • [22] Proteasome inhibition enhances the stability of mouse Cu/Zn superoxide dismutase with mutations linked to familial amyotrophic lateral sclerosis
    Hoffman, EK
    Wilcox, HM
    Scott, RW
    Siman, R
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 139 (01) : 15 - 20
  • [23] Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models
    Kato, S
    Kato, M
    Abe, Y
    Matsumura, T
    Nishino, T
    Aoki, M
    Itoyama, Y
    Asayama, K
    Awaya, A
    Hirano, A
    Ohama, E
    ACTA NEUROPATHOLOGICA, 2005, 110 (02) : 101 - 112
  • [24] Mutant Cu,Zn superoxide dismutases and familial amyotrophic lateral sclerosis: Evaluation of oxidative hypotheses
    Liochev, SI
    Fridovich, I
    FREE RADICAL BIOLOGY AND MEDICINE, 2003, 34 (11) : 1383 - 1389
  • [25] CU/ZN SUPEROXIDE-DISMUTASE ACTIVITY IN FAMILIAL AND SPORADIC AMYOTROPHIC-LATERAL-SCLEROSIS
    ROBBERECHT, W
    SAPP, P
    VIAENE, MK
    ROSEN, D
    MCKENNAYASEK, D
    HAINES, J
    HORVITZ, R
    THEYS, P
    BROWN, R
    JOURNAL OF NEUROCHEMISTRY, 1994, 62 (01) : 384 - 387
  • [26] Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase
    Gurney, ME
    Cutting, FB
    Zhai, P
    Andrus, PK
    Hall, ED
    PATHOLOGIE BIOLOGIE, 1996, 44 (01): : 51 - 56
  • [27] New mutation in the SOD1 (copper/zinc superoxide dismutase-1) gene in a Chinese amyotrophic lateral sclerosis (ALS) patient
    Cui, Fang
    Cai, Wanshi
    Wang, Zhanjun
    Ren, Yuting
    Li, Mao
    Sun, Zhongsheng
    Huang, Xusheng
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2013, 14 (7-8) : 635 - 637
  • [28] FAMILIAL AMYOTROPHIC-LATERAL-SCLEROSIS WITH A MUTATION IN THE CU/ZN SUPEROXIDE-DISMUTASE GENE
    TAKAHASHI, H
    MAKIFUCHI, T
    NAKANO, R
    SATO, S
    INUZUKA, T
    SAKIMURA, K
    MISHINA, M
    HONMA, Y
    TSUJI, S
    IKUTA, F
    ACTA NEUROPATHOLOGICA, 1994, 88 (02) : 185 - 188
  • [29] Mutations in Superoxide Dismutase 1 (Sod1) Linked to Familial Amyotrophic Lateral Sclerosis Can Disrupt High-Affinity Zinc-Binding Promoted by the Copper Chaperone for Sod1 (Ccs)
    Boyd, Stefanie D.
    Ullrich, Morgan S.
    Calvo, Jenifer S.
    Behnia, Fatemeh
    Meloni, Gabriele
    Winkler, Duane D.
    MOLECULES, 2020, 25 (05):
  • [30] Instability of mutant Cu/Zn superoxide dismutase (Ala4Thr) associated with familial amyotrophic lateral sclerosis
    Nakano, R
    Inuzuka, T
    Kikugawa, K
    Takahashi, H
    Sakimura, K
    Fujii, J
    Taniguchi, N
    Tsuji, S
    NEUROSCIENCE LETTERS, 1996, 211 (02) : 129 - 131